Skip to main content

Global Registry for Endovascular Aortic Treatment (GREAT)

Active, not recruiting · NCT01658787

Conditions: Multiple Pathologies

At a glance

Research payments reported, 2025
$252,378
U.S. investigators named
46
Sites paid
43
Planned or actual enrollment
4,600

About the trial

Sponsor
W.L.Gore & Associates
Tested
Endovascular aortic repair (device)
Dates
Started 2010-12; completion 2027-06
Results posted
Not yet

Prospective, observational Registry to obtain data on device performance and clinical outcomes.

From ClinicalTrials.gov, last updated 2026-02-09. Full record, eligibility and contacts (opens in a new tab)

Industry funding

W. L. Gore & Associates, Inc. reported $252,378 in research payments for this study in 2025 (87 payments).

Products named: Product in Development

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.